News & Analysis on Clinical Trial Services & Contract Research And Development
With active pharmaceutical ingredient sales of $1,460m (€960.8m) in 2007 and a portfolio of more than 250 compounds, Teva Pharmaceutical Industries is by a long stretch the dominant supplier in the global API market.
A long-acting injectable formulation of Eli Lilly's blockbuster schizophrenia treatment Zyprexa (olanzapine), with the potential to improve patient adherence and take some of the sting out of generic competition three years down the line, has fallen...
A UK chemicals plant has become the latest casualty of GlaxoSmithKline's (GSK's) pledge to make the business leaner with the help of outsourcing and offshoring.
Life sciences systems maker Bruker Corp reported stronger-than-expected fourth-quarter earnings and revenue results on the back of the company's recent $1.1bn acquisition of affiliated firm Bruker BioSpin.
German chemicals giant BASF has announced its latest brace of price rises, this time for two forms of carboxylic acid and for bleaching and reducing agents.